Exelixis (EXEL) Restructuring Costs (2010 - 2026)

Exelixis' (EXEL) quarterly Restructuring Costs came in at $694000.0 in Q1 2026, up 136.05% year-on-year from $294000.0 in Q1 2025, and down 96.5% quarter-over-quarter from $19.8 million in Q4 2025.

Exelixis (EXEL) Restructuring Costs (2010 - 2026) Analysis & Trends

Exelixis' Restructuring Costs history runs 11 years deep, the most recent figure standing at $694000.0 for Q1 2026.

  • On a quarterly basis, Restructuring Costs rose 136.05% year-over-year to $694000.0 in Q1 2026; TTM through Jan 2026 was $20.5 million, a 39.14% decrease from a year earlier, with the FY2026 full-year figure at $20.5 million, down 39.14% from the prior year.
  • Restructuring Costs slipped to $694000.0 in Q1 2026 per EXEL's latest filing, from $19.8 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $32.8 million in Q1 2024 and bottomed at $96000.0 in Q3 2024.
  • The 3-year median for Restructuring Costs is $584500.0 (2024), against an average of $9.0 million.
  • Across the five-year window, Restructuring Costs jumped 20541.67% in 2025 and soared 136.05% in 2026, its largest moves.
  • Year by year, Restructuring Costs stood at $96000.0 in 2024, then soared by 20541.67% to $19.8 million in 2025, then slumped by 96.5% to $694000.0 in 2026.
  • Per Business Quant, the three latest EXEL Restructuring Costs figures stand at $694000.0 (Q1 2026), $19.8 million (Q4 2025), and $294000.0 (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Jan 2, 2026 694,000.00
Oct 3, 2025 19.82 Mn
Jan 3, 2025 294,000.00
Sep 27, 2024 96,000.00
Jun 28, 2024 475,000.00
Mar 29, 2024 32.84 Mn
Jun 30, 2017 -60,000.00
Mar 31, 2017 28,000.00
Dec 30, 2016 -228,000.00
Sep 30, 2016 -244,000.00
Jun 30, 2016 1.02 Mn
Mar 31, 2016 94,000.00
Sep 30, 2015 282,000.00
Jun 30, 2015 1.29 Mn
Mar 31, 2015 -431,000.00
Dec 31, 2014 3.46 Mn
Sep 30, 2014 3.76 Mn
Jun 30, 2014 331,000.00
Mar 31, 2014 46,000.00
Dec 31, 2013 366,000.00